Results of API‐AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study

Volume: 146, Issue: 2, Pages: 413 - 423
Published: Jan 15, 2020
Abstract
In the OS2006 study, patients younger than 18 years were treated with a methotrexate-based regimen (MTX), patients older than 25 years with a doxorubicin-cisplatin-ifosfamide-based regimen (API-AI), whereas patients aged 18-25 years received either API-AI or MTX. We herein report the prespecified subgroup analysis of the outcome of 106 patients treated with API-AI. Preoperative chemotherapy combined three doxorubicin-ifosfamide-cisplatin (API)...
Paper Details
Title
Results of API‐AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome‐09 study
Published Date
Jan 15, 2020
Volume
146
Issue
2
Pages
413 - 423
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.